BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 26187363)

  • 1. Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.
    Eigl S; Prattes J; Reinwald M; Thornton CR; Reischies F; Spiess B; Neumeister P; Zollner-Schwetz I; Raggam RB; Flick H; Buchheidt D; Krause R; Hoenigl M
    Int J Antimicrob Agents; 2015 Oct; 46(4):401-5. PubMed ID: 26187363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.
    Prattes J; Lackner M; Eigl S; Reischies F; Raggam RB; Koidl C; Flick H; Wurm R; Palfner M; Wölfler A; Neumeister P; Thornton CR; Krause R; Lass-Flörl C; Hoenigl M
    Mycoses; 2015 Aug; 58(8):461-9. PubMed ID: 26103209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
    J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.
    Johnson GL; Sarker SJ; Nannini F; Ferrini A; Taylor E; Lass-Flörl C; Mutschlechner W; Bustin SA; Agrawal SG
    J Clin Microbiol; 2015 Jul; 53(7):2103-8. PubMed ID: 25903568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of lateral flow device and galactomannan for the detection of Aspergillus species in bronchoalveolar fluid of patients at risk for invasive pulmonary aspergillosis.
    Miceli MH; Goggins MI; Chander P; Sekaran AK; Kizy AE; Samuel L; Jiang H; Thornton CR; Ramesh M; Alangaden G
    Mycoses; 2015 Jun; 58(6):368-74. PubMed ID: 25996144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Testing the performance of a prototype lateral flow device using bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in high-risk patients.
    Castillo CG; Kauffman CA; Zhai J; Jiang H; Agozino SM; Miceli MH
    Mycoses; 2018 Jan; 61(1):4-10. PubMed ID: 28905439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
    Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
    Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
    Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
    Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of the newly formatted lateral-flow device for invasive pulmonary aspergillosis.
    Hoenigl M; Eigl S; Heldt S; Duettmann W; Thornton C; Prattes J
    Mycoses; 2018 Jan; 61(1):40-43. PubMed ID: 28922489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients.
    Eigl S; Prattes J; Lackner M; Willinger B; Spiess B; Reinwald M; Selitsch B; Meilinger M; Neumeister P; Reischies F; Wölfler A; Raggam RB; Flick H; Eschertzhuber S; Krause R; Buchheidt D; Thornton CR; Lass-Flörl C; Hoenigl M
    Crit Care; 2015 Apr; 19(1):178. PubMed ID: 25927915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of bronchoalveolar lavage galactomannan on the outcome of patients at risk for invasive pulmonary aspergillosis.
    Danpornprasert P; Foongladda S; Tscheikuna J
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S86-93. PubMed ID: 20364562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing Invasive Pulmonary Aspergillosis in Hematology Patients: a Retrospective Multicenter Evaluation of a Novel Lateral Flow Device.
    Mercier T; Schauwvlieghe A; de Kort E; Dunbar A; Reynders M; Guldentops E; Rijnders B; Verweij PE; Lagrou K; Maertens J
    J Clin Microbiol; 2019 Apr; 57(4):. PubMed ID: 30651395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchoalveolar lavage fluid galactomannan detection for diagnosis of invasive pulmonary aspergillosis in chronic obstructive pulmonary disease.
    Zhang XB; Chen GP; Lin QC; Lin X; Zhang HY; Wang JH
    Med Mycol; 2013 Oct; 51(7):688-95. PubMed ID: 23527739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis.
    Jung J; Kim MY; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Microbiol Immunol Infect; 2018 Dec; 51(6):802-809. PubMed ID: 28712819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Galactomannan Tests of Bronchoalveolar Lavage Fluid for Diagnosing Invasive Pulmonary Aspergillosis].
    Deng J; Wu SY; Liu Y; Ma Y; Xie Y; Chen ZX; Dai ZQ; Deng JL; Kang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 49(1):124-128. PubMed ID: 29737102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galactomannan detection in bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in patients with hematological diseases-the role of factors affecting assay performance.
    Racil Z; Kocmanova I; Toskova M; Buresova L; Weinbergerova B; Lengerova M; Rolencova M; Winterova J; Hrncirova K; Volfova P; Skrickova J; Mayer J
    Int J Infect Dis; 2011 Dec; 15(12):e874-81. PubMed ID: 22040924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel tests for diagnosis of invasive aspergillosis in patients with underlying respiratory diseases.
    Prattes J; Flick H; Prüller F; Koidl C; Raggam RB; Palfner M; Eigl S; Buzina W; Zollner-Schwetz I; Thornton CR; Krause R; Hoenigl M
    Am J Respir Crit Care Med; 2014 Oct; 190(8):922-9. PubMed ID: 25203869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
    Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
    Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.